Ana Marques1, Inês Cruz1, Daniel Caldeira1,2,3,4, Sofia Alegria1, Ana Catarina Gomes1, Ana Luísa Broa1, Isabel João1, Hélder Pereira1. 1. Hospital Garcia de Orta EPE Almada - Portugal. 2. Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa Lisbon, Portugal. 3. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon, Portugal. 4. Centro Cardiovascular da Universidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa Lisbon, Portugal.
Abstract
BACKGROUND: Infective endocarditis (IE) is associated with severe complications and high mortality. The assessment of mortality rates and predictors for fatal events is important to identify modifiable factors related to the pattern of treatment, in order to improve outcomes. OBJECTIVES: We sought to evaluate clinical outcomes of patients with IE and to determine predictors of in-hospital mortality. METHODS: Retrospective single-center study including patients with IE admitted during a 10-year period (2006-2015). Data on comorbidities, clinical presentation, microbiology and clinical outcomes during hospitalization were evaluated. Risk factors of in-hospital death were analyzed. A p-value < 0.05 was considered significant. RESULTS: A total of 134 cases were included (73% males, mean age of 61 ± 16 years-old). Half of them had previous valvular heart disease. Healthcare-associated IE and negative blood-cultures occurred in 22% and prosthetic IE in 25%. The aortic valve was the one most often affected by infection. Staphylococcus aureus was the most commonly isolated microorganism. Forty-four (32.8%) patients underwent cardiac surgery. The in-hospital mortality rate was 31.3% (42 patients). The identified risk factors for in-hospital mortality were Staphylococcus aureus etiology (OR 6.47; 95% CI: 1.07-39.01; p = 0.042), negative blood-cultures (OR 9.14; 95% CI: 1.42-58.77; p = 0.02), evidence of valve obstruction in echocardiography (OR 8.57; 95% CI: 1.11-66.25; p = 0.039), clinical evolution with heart failure (OR 4.98; 95%CI: 1.31-18.92; p = 0.018) or septic shock (OR 20.26; 95% CI: 4.04-101.74; p < 0.001). Cardiac surgery was a protective factor of mortality (OR 0.14; 95% CI 0.03-0.65; p = 0.012). CONCLUSION: The risk factors for in-hospital mortality were clinical (heart failure, septic shock), evidence of valve obstruction in echocardiography, Staphylococcus aureus etiology or negative blood cultures. Invasive treatment by surgery significantly decreased the mortality risk.
BACKGROUND:Infective endocarditis (IE) is associated with severe complications and high mortality. The assessment of mortality rates and predictors for fatal events is important to identify modifiable factors related to the pattern of treatment, in order to improve outcomes. OBJECTIVES: We sought to evaluate clinical outcomes of patients with IE and to determine predictors of in-hospital mortality. METHODS: Retrospective single-center study including patients with IE admitted during a 10-year period (2006-2015). Data on comorbidities, clinical presentation, microbiology and clinical outcomes during hospitalization were evaluated. Risk factors of in-hospital death were analyzed. A p-value < 0.05 was considered significant. RESULTS: A total of 134 cases were included (73% males, mean age of 61 ± 16 years-old). Half of them had previous valvular heart disease. Healthcare-associated IE and negative blood-cultures occurred in 22% and prosthetic IE in 25%. The aortic valve was the one most often affected by infection. Staphylococcus aureus was the most commonly isolated microorganism. Forty-four (32.8%) patients underwent cardiac surgery. The in-hospital mortality rate was 31.3% (42 patients). The identified risk factors for in-hospital mortality were Staphylococcus aureus etiology (OR 6.47; 95% CI: 1.07-39.01; p = 0.042), negative blood-cultures (OR 9.14; 95% CI: 1.42-58.77; p = 0.02), evidence of valve obstruction in echocardiography (OR 8.57; 95% CI: 1.11-66.25; p = 0.039), clinical evolution with heart failure (OR 4.98; 95%CI: 1.31-18.92; p = 0.018) or septic shock (OR 20.26; 95% CI: 4.04-101.74; p < 0.001). Cardiac surgery was a protective factor of mortality (OR 0.14; 95% CI 0.03-0.65; p = 0.012). CONCLUSION: The risk factors for in-hospital mortality were clinical (heart failure, septic shock), evidence of valve obstruction in echocardiography, Staphylococcus aureus etiology or negative blood cultures. Invasive treatment by surgery significantly decreased the mortality risk.
Authors: João Pedro Ferreira; Filipa Gomes; Patrícia Rodrigues; Miguel Araújo Abreu; José Miguel Maia; Paulo Bettencourt; André Luz; Severo Torres; João Araújo Correia Journal: Rev Port Cardiol Date: 2013-10-25 Impact factor: 1.374
Authors: Tahaniyat Lalani; Vivian H Chu; Lawrence P Park; Enrico Cecchi; G Ralph Corey; Emanuele Durante-Mangoni; Vance G Fowler; David Gordon; Paolo Grossi; Margaret Hannan; Bruno Hoen; Patricia Muñoz; Hussien Rizk; Souha S Kanj; Christine Selton-Suty; Daniel J Sexton; Denis Spelman; Veronica Ravasio; Marie Françoise Tripodi; Andrew Wang Journal: JAMA Intern Med Date: 2013-09-09 Impact factor: 21.873
Authors: Carmen Olmos; Isidre Vilacosta; Cristina Fernández; Javier López; Cristina Sarriá; Carlos Ferrera; Ana Revilla; Jacobo Silva; David Vivas; Isabel González; José Alberto San Román Journal: Eur Heart J Date: 2012-10-11 Impact factor: 29.983
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Lucy E Wilson; David L Thomas; Jacqueline Astemborski; Terri L Freedman; David Vlahov Journal: J Infect Dis Date: 2002-05-31 Impact factor: 5.226
Authors: Emilio García-Cabrera; Nuria Fernández-Hidalgo; Benito Almirante; Radka Ivanova-Georgieva; Mariam Noureddine; Antonio Plata; Jose M Lomas; Juan Gálvez-Acebal; Carmen Hidalgo-Tenorio; Josefa Ruíz-Morales; Francisco J Martínez-Marcos; Jose M Reguera; Javier de la Torre-Lima; Arístides de Alarcón González Journal: Circulation Date: 2013-05-06 Impact factor: 29.690
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835
Authors: Carlos Bea; Sara Vela; Sergio García-Blas; Jose-Angel Perez-Rivera; Pablo Díez-Villanueva; Ana Isabel de Gracia; Eladio Fuertes; Maria Rosa Oltra; Ana Ferrer; Andreu Belmonte; Enrique Santas; Mauricio Pellicer; Javier Colomina; Alberto Doménech; Vicente Bodi; Maria José Forner; Francisco Javier Chorro; Clara Bonanad Journal: J Cardiovasc Dev Dis Date: 2022-06-17
Authors: Mazin Barry; Syed Abdul Bari; Muhammad Yasin Akhtar; Faizah Al Nahdi; Richilda Erlandez; Abdullah Al Khushail; Yahya Al Hebaishi Journal: J Epidemiol Glob Health Date: 2021-11-04